SpaceX, OpenAI, and Anthropic carry a combined valuation of $2.8T to $3T, with SpaceX alone expected to raise $50B - $70B in ...
The IPO class of 2026 is likely to receive its first incumbent, after Aktis Oncology set its sights on a public listing that could see proceeds of around $210m. The cancer treatment-focused biotech ...
Hosted on MSN
2026’s IPO lineup is getting dangerous
Something big is lining up for 2026, and it’s not just another IPO cycle. Wall Street is staring at one of the most crowded public-market queues in years, with 190+ companies racing toward the exit at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results